Health Economics & Outcomes Research (HEOR) & Market Access — Evidence from the Sites We Manage
Health Economics & Outcomes Research (HEOR)
and
Market Access
As a full-service Site Management Organization (SMO) and CRO, we generate real-world evidence at the sites we manage — connecting site-level data directly to your HEOR and market-access story.
At Deqa Wa Seha, we understand that successful product adoption and reimbursement depend not only on clinical efficacy but also on demonstrating clear economic value and real-world outcomes.
Our HEOR and Market Access services bridge the gap between clinical data and healthcare decision-making to maximize market penetration and patient access worldwide.
Global Insights with a US Foundation
Rooted in deep expertise from the US healthcare landscape, we provide strategic insights that inform value demonstration across diverse healthcare systems. By leveraging US HEOR methodologies and payer engagement experience, we help clients shape compelling evidence, while adapting approaches to meet the unique needs of Asia-Pacific (APAC), the Middle East, and African markets — and, as an SMO, we can collect that evidence directly through the directly-managed and partner sites we operate across global markets.
What We Offer:
- Site-Based Evidence Generation (SMO)
Full-service management of the sites that produce your real-world and registry data, from activation to data lock. - Health Economic Modeling & Budget Impact Analysis
Develop robust models that forecast product value and budget impact in target healthcare environments, enabling payers and providers to make informed decisions. - Real-World Evidence (RWE) Generation
Design and implement patient-centric, data-driven studies, including observational research and registry development, to demonstrate treatment effectiveness in routine clinical practice.As an SMO, we run these studies inside the sites we manage — improving data quality and speed at the source.
- Value Proposition Development & Pricing Strategy
Craft tailored value frameworks aligned with regional payer expectations, optimizing pricing strategies to enhance access and reimbursement outcomes. - Market Access Strategy & Payer Engagement
Support early and ongoing dialogue with payers and health technology assessment (HTA) bodies worldwide, ensuring alignment between evidence generation and market needs. - Cross-Regional Adaptation & Comparative Effectiveness Research
Customize HEOR strategies to accommodate the economic, cultural, and regulatory landscapes of Asia-Pacific (APAC), the Middle East, and Africa, underpinning evidence with relevant local data and comparisons.
Why Partner with Deqa Wa Seha?
Our global perspective, combined with specialized regional expertise, enables us to deliver HEOR and market access solutions that drive meaningful outcomes.
With Deqa Wa Seha, unlock the true value of your innovations—delivering evidence-based strategies that not only meet payer requirements but also improve patient access worldwide.
And because we are a full-service SMO, we control the sites that generate your evidence — one partner from data collection to value story.
Success Stories
Accelerating Market Access for a Novel Oncology Therapy Across Asia-Pacific (APAC) and MEA
Challenge:
A global pharmaceutical company developing an innovative oncology therapy faced complex market access hurdles across diverse Asia-Pacific (APAC), Middle Eastern and African markets, each with unique payer requirements and health economic landscapes.
Solution:
Deqa Wa Seha designed and executed a customized HEOR strategy grounded in US-based economic modeling but adapted for local contexts. We developed regional budget impact models, real-world evidence studies, and payer-targeted value dossiers.
Outcome:
Our strategic approach shortened payer review times by 30%, increased reimbursement approvals across five key markets, and facilitated early patient access programs that enhanced uptake. The client reported successful launches supported by strong value communication customized to each region.
Enhanced Value Demonstration for a Rare Disease Product in Emerging Markets
Challenge:
A biotech company needed to demonstrate clear economic and clinical value for a rare disease medication to secure reimbursement and broaden patient access in challenging emerging markets in Africa and the Middle East.
Solution:
Our team conducted comprehensive comparative effectiveness research alongside real-world evidence collection to provide compelling data on clinical benefits and healthcare resource utilization. We integrated local stakeholder insights to build culturally relevant value propositions and pricing strategies.
Outcome:
The client achieved a 40% increase in successful reimbursement negotiations within the first year, expanding market presence and significantly improving patient access in previously underserved countries.
Turn Your Evidence Into Access
Real-world evidence and economic modeling only pay off when they reach the right decision-makers in the right markets. The earlier you plan that evidence, the stronger your position when it counts.
Where we help
- Evidence strategy aligned to the markets and payers you are targeting.
- Real-world evidence generation built alongside your clinical program.
- Health economic and outcomes analysis that supports access, not just approval.
Let us help you plan the evidence your study needs from the outset — before the questions arrive.